Bacterial cell wall, cytoplasmic membrane, and DNA

The bacterial cell wall, cytoplasmic membrane, and DNA represent three fundamental pillars of bacterial viability and are the primary targets for the majority of clinically used antibiotics. The cell wall, characterized by its peptidoglycan layer, maintains cell shape and prevents osmotic bursting, making it a target for beta-lactams like penicillin (StatPearls, 2023). The cytoplasmic membrane serves as a critical barrier for ion regulation and ATP synthesis; drugs like daptomycin and polymyxins disrupt this membrane to cause rapid cell death (PubMed, 2021). Bacterial DNA is the repository of genetic information, and its replication is essential for cell division. Fluoroquinolones target DNA gyrase and topoisomerase IV to prevent DNA supercoiling and replication, while other agents like metronidazole cause direct DNA strand breakage (NIH, 2022). Targeting these structures allows for selective toxicity because bacterial cell walls and specific DNA-handling enzymes differ significantly from those in human cells. However, the emergence of multi-drug resistant bacteria poses a significant challenge to therapies hitting these targets.

Other names

Bacterial structural componentsProkaryotic cell targetsAntimicrobial targets

Inhibition of cell wall peptidoglycan assembly, disruption of cytoplasmic membrane integrity, and interference with DNA replication or structural stability (StatPearls, 2023; PubMed, 2021).